CN102507918A - 抗环瓜氨酸肽抗体测定试剂盒 - Google Patents
抗环瓜氨酸肽抗体测定试剂盒 Download PDFInfo
- Publication number
- CN102507918A CN102507918A CN2011103522368A CN201110352236A CN102507918A CN 102507918 A CN102507918 A CN 102507918A CN 2011103522368 A CN2011103522368 A CN 2011103522368A CN 201110352236 A CN201110352236 A CN 201110352236A CN 102507918 A CN102507918 A CN 102507918A
- Authority
- CN
- China
- Prior art keywords
- reagent
- ccp
- antibody
- kit
- citrullinated peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 18
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 57
- 229910021642 ultra pure water Inorganic materials 0.000 claims abstract description 14
- 239000012498 ultrapure water Substances 0.000 claims abstract description 14
- 239000004094 surface-active agent Substances 0.000 claims abstract description 10
- 238000013016 damping Methods 0.000 claims description 16
- 239000012530 fluid Substances 0.000 claims description 16
- 150000003839 salts Chemical class 0.000 claims description 13
- 101100046775 Arabidopsis thaliana TPPA gene Proteins 0.000 claims description 12
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 12
- 238000012986 modification Methods 0.000 claims description 12
- 230000004048 modification Effects 0.000 claims description 12
- XZZNDPSIHUTMOC-UHFFFAOYSA-N triphenyl phosphate Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)(=O)OC1=CC=CC=C1 XZZNDPSIHUTMOC-UHFFFAOYSA-N 0.000 claims description 12
- 230000002421 anti-septic effect Effects 0.000 claims description 8
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 6
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 6
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 6
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims description 6
- 229940033663 thimerosal Drugs 0.000 claims description 6
- 239000012634 fragment Substances 0.000 claims description 4
- 239000011806 microball Substances 0.000 claims description 2
- 238000001514 detection method Methods 0.000 abstract description 19
- 239000004793 Polystyrene Substances 0.000 abstract description 17
- 238000000034 method Methods 0.000 abstract description 7
- 230000035945 sensitivity Effects 0.000 abstract description 7
- 239000004816 latex Substances 0.000 abstract description 6
- 229920000126 latex Polymers 0.000 abstract description 6
- 238000004879 turbidimetry Methods 0.000 abstract description 5
- 230000003321 amplification Effects 0.000 abstract description 2
- 239000004005 microsphere Substances 0.000 abstract description 2
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 2
- 239000007853 buffer solution Substances 0.000 abstract 2
- 229910017053 inorganic salt Inorganic materials 0.000 abstract 2
- 239000003755 preservative agent Substances 0.000 abstract 2
- 230000002335 preservative effect Effects 0.000 abstract 2
- 230000005540 biological transmission Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 16
- 239000000203 mixture Substances 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 6
- 206010039073 rheumatoid arthritis Diseases 0.000 description 6
- 241000283707 Capra Species 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241000272525 Anas platyrhynchos Species 0.000 description 2
- 241000272814 Anser sp. Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 2
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229960002173 citrulline Drugs 0.000 description 2
- 235000013477 citrulline Nutrition 0.000 description 2
- 238000011984 electrochemiluminescence immunoassay Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 108010022355 Fibroins Proteins 0.000 description 1
- HVVWZTWDBSEWIH-UHFFFAOYSA-N [2-(hydroxymethyl)-3-prop-2-enoyloxy-2-(prop-2-enoyloxymethyl)propyl] prop-2-enoate Chemical compound C=CC(=O)OCC(CO)(COC(=O)C=C)COC(=O)C=C HVVWZTWDBSEWIH-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 108010061103 cyclic citrullinated peptide Proteins 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
PB缓冲液 | 0.4% |
无机盐 | 1% |
TWEEN20 | 0.05% |
ProClin300 | 0.02% |
干扰清除蛋白 (Roche ) | 0.02% |
(修饰的)CCP至敏的纳米PS微球 | 0.1% |
超纯水 | 98.41% |
PB缓冲液 | 0.4% |
无机盐 | 1% |
TWEEN 20 | 0.05% |
ProClin300 | 0.02% |
羊抗人IgG-FC抗体 | 0.001% |
超纯水 | 98.529% |
PB缓冲液 | 5% |
无机盐 | 5% |
Emulgen120 | 1% |
叠氮钠 | 0.1% |
干扰清除蛋白 (scantibodies) | 0.1% |
(修饰的)CCP至敏的纳米PS微球 | 0.06% |
超纯水 | 88.74% |
PB缓冲液 | 5% |
无机盐 | 5% |
EMULGEN120 | 1% |
叠氮钠 | 0.1% |
羊抗人IgG-FC抗体 | 0.3% |
超纯水 | 88.6% |
Goods’缓冲液 | 10% |
无机盐 | 10% |
TX100 | 2% |
硫柳汞 | 0.2% |
干扰清除蛋白(Roche ) | 0.2% |
(修饰的)CCP至敏的纳米PS微球 | 0.05% |
超纯水 | 77.55% |
PB缓冲液 | 10% |
无机盐 | 10% |
TX100 | 2% |
硫柳汞 | 0.2% |
羊抗人IgG-FC抗体 | 0.5% |
超纯水 | 77.3% |
雅培试剂测定的混合样本浓度(U/ml) | 实施例1(△A) | 实施例2(△A) | 实施例3(△A) |
0 | 0.0005 | -0.0011 | 0.0021 |
4.98 | 245 | 599 | 1257 |
25.12 | 449 | 1026 | 1729 |
51.07 | 801 | 1437 | 2219 |
99.21 | 1382 | 2103 | 2831 |
201.36 | 1803 | 2592 | 3314 |
R1试剂 | 对比例1 | 对比例2 | 对比例3 |
Buffer | 0.4%(PB) | 5%(PB) | 10%(Goods’ ) |
无机盐 | 1% | 5% | 10% |
表面活性剂 | 0.05%(TWEEN20 ) | 1%(EMULGEN120) | 2%(TX100) |
防腐剂 | 0.02%(ProClin300) | 0.1%(叠氮钠) | 0.2%(硫柳汞) |
干扰清除蛋白 | 0.02%(Roche ) | 0.1%(scantibodies) | 0.2%(Roche ) |
超纯水 | 98.51% | 88.80% | 77.60% |
R2试剂 | 对比例1 | 对比例2 | 对比例3 |
Buffer | 0.4%(PB) | 5%(PB) | 10%(Goods’ ) |
无机盐 | 1% | 5% | 10% |
(修饰的)CCP至敏的纳米PS微球 | 0.1% (Φ60nm) | 0.3% (Φ200nm) | 0.5% (Φ500nm) |
表面活性剂 | 0.05%(TWEEN20) | 1%(EMULGEN120) | 2%(TX100) |
防腐剂 | 0.02%(ProClin300) | 0.1%(叠氮钠) | 0.2%(硫柳汞) |
超纯水 | 98.43% | 88.6% | 77.3% |
R1:R2(配合比例按重量百分数计) | 1:1 | 5:1 | 9:1 |
雅培试剂测定的混合样本浓度(U/ml) | 对比例1(△A) | 对比例2(△A) | 对比例3(△A) |
0 | -0.0007 | 0.0005 | 0.0019 |
4.98 | 29 | 68 | 175 |
25.12 | 63 | 134 | 417 |
51.07 | 188 | 417 | 891 |
99.21 | 446 | 719 | 1790 |
201.36 | 838 | 1423 | 3124 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110352236.8A CN102507918B (zh) | 2011-11-09 | 2011-11-09 | 抗环瓜氨酸肽抗体测定试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110352236.8A CN102507918B (zh) | 2011-11-09 | 2011-11-09 | 抗环瓜氨酸肽抗体测定试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102507918A true CN102507918A (zh) | 2012-06-20 |
CN102507918B CN102507918B (zh) | 2014-10-29 |
Family
ID=46220024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110352236.8A Active CN102507918B (zh) | 2011-11-09 | 2011-11-09 | 抗环瓜氨酸肽抗体测定试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102507918B (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102914656A (zh) * | 2012-07-23 | 2013-02-06 | 四川省新成生物科技有限责任公司 | 间接免疫法糖化血清白蛋白检测试剂盒及测定方法 |
CN104198725A (zh) * | 2014-08-14 | 2014-12-10 | 上海睿康生物科技有限公司 | 抗环瓜氨酸肽抗体检测试剂盒 |
CN104764888A (zh) * | 2015-05-04 | 2015-07-08 | 潍坊市康华生物技术有限公司 | 一种抗环瓜氨酸肽抗体检测试剂盒 |
CN105548557A (zh) * | 2015-12-08 | 2016-05-04 | 苏州德沃生物技术有限公司 | 超敏乳胶增强免疫比浊检测试剂及其检测方法和应用 |
CN106153946A (zh) * | 2016-06-22 | 2016-11-23 | 浙江达美生物技术有限公司 | 一种抗环瓜氨酸肽的测定试剂及其制备方法 |
CN107390742A (zh) * | 2017-08-04 | 2017-11-24 | 天津理工大学 | 一种基于ladrc的全自动酶免分析仪孵育温控系统及工作方法 |
CN108456253A (zh) * | 2018-02-09 | 2018-08-28 | 中国科学院广州生物医药与健康研究院 | 一种重金属离子特异性二抗及其制备方法和应用 |
CN109100515A (zh) * | 2018-09-14 | 2018-12-28 | 苏州普瑞斯生物科技有限公司 | 一种测定抗环瓜氨酸肽抗体浓度的试剂盒及其制备方法 |
CN109724929A (zh) * | 2018-12-26 | 2019-05-07 | 镇江金太医学检验实验室有限公司 | 一种抗坏瓜氨酸肽抗体的检测方法 |
CN110824160A (zh) * | 2019-11-27 | 2020-02-21 | 迪亚莱博(张家港)生物科技有限公司 | 抗环瓜氨酸肽抗体检测试剂盒及其制备方法 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030003503A1 (en) * | 2001-06-29 | 2003-01-02 | Tsai Tenlin S. | Enhancing sensitivity and equimolar detection through modifications of the reaction environment |
WO2005064307A2 (en) * | 2003-12-23 | 2005-07-14 | Roche Diagnostics Gmbh | Method of assessing rheumatoid arthritis by measuring anti-ccp and interleukin 6 |
CN1796997A (zh) * | 2004-12-22 | 2006-07-05 | 上海富纯中南生物技术有限公司 | 诊断ra的检测试剂盒、制备及完成质量检测标准的方法 |
WO2007000169A2 (en) * | 2005-06-29 | 2007-01-04 | Genmab A/S | Non-human mammalian arthritis model featuring human antibodies against citrullinated proteins |
CN101377492A (zh) * | 2007-08-29 | 2009-03-04 | 北京九强生物技术有限公司 | 胱抑素c测定试剂盒 |
CN101432626A (zh) * | 2006-04-04 | 2009-05-13 | 神谷来克斯公司 | 用于肌钙蛋白分析的高灵敏系统和方法 |
CN101957365A (zh) * | 2009-07-21 | 2011-01-26 | 卫生部北京医院 | 检测抗环瓜氨酸肽和抗免疫球蛋白g双特异性抗体的试剂盒 |
CN101995463A (zh) * | 2009-08-14 | 2011-03-30 | 上海荣盛生物药业有限公司 | 用于斑点金免疫渗滤法检测类风湿关节炎免疫抗体的组合物 |
CN102007413A (zh) * | 2008-02-20 | 2011-04-06 | 阿克斯-希尔德诊断有限公司 | 抗环瓜氨酸肽抗体的检测方法 |
-
2011
- 2011-11-09 CN CN201110352236.8A patent/CN102507918B/zh active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030003503A1 (en) * | 2001-06-29 | 2003-01-02 | Tsai Tenlin S. | Enhancing sensitivity and equimolar detection through modifications of the reaction environment |
WO2005064307A2 (en) * | 2003-12-23 | 2005-07-14 | Roche Diagnostics Gmbh | Method of assessing rheumatoid arthritis by measuring anti-ccp and interleukin 6 |
EP1882946A2 (en) * | 2003-12-23 | 2008-01-30 | Roche Diagnostics GmbH | Method of assessing rheumatoid arthritis by measuring anti-CCP and interleukin 6 |
CN1796997A (zh) * | 2004-12-22 | 2006-07-05 | 上海富纯中南生物技术有限公司 | 诊断ra的检测试剂盒、制备及完成质量检测标准的方法 |
WO2007000169A2 (en) * | 2005-06-29 | 2007-01-04 | Genmab A/S | Non-human mammalian arthritis model featuring human antibodies against citrullinated proteins |
CN101432626A (zh) * | 2006-04-04 | 2009-05-13 | 神谷来克斯公司 | 用于肌钙蛋白分析的高灵敏系统和方法 |
CN101377492A (zh) * | 2007-08-29 | 2009-03-04 | 北京九强生物技术有限公司 | 胱抑素c测定试剂盒 |
CN102007413A (zh) * | 2008-02-20 | 2011-04-06 | 阿克斯-希尔德诊断有限公司 | 抗环瓜氨酸肽抗体的检测方法 |
CN101957365A (zh) * | 2009-07-21 | 2011-01-26 | 卫生部北京医院 | 检测抗环瓜氨酸肽和抗免疫球蛋白g双特异性抗体的试剂盒 |
CN101995463A (zh) * | 2009-08-14 | 2011-03-30 | 上海荣盛生物药业有限公司 | 用于斑点金免疫渗滤法检测类风湿关节炎免疫抗体的组合物 |
Non-Patent Citations (1)
Title |
---|
陈炳阳等: "抗环瓜氨酸肽抗体对类风湿性关节炎的诊断价值", 《检验医学与临床》 * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102914656B (zh) * | 2012-07-23 | 2014-10-29 | 四川新健康成生物股份有限公司 | 间接免疫法糖化血清白蛋白检测试剂盒 |
CN102914656A (zh) * | 2012-07-23 | 2013-02-06 | 四川省新成生物科技有限责任公司 | 间接免疫法糖化血清白蛋白检测试剂盒及测定方法 |
CN104198725A (zh) * | 2014-08-14 | 2014-12-10 | 上海睿康生物科技有限公司 | 抗环瓜氨酸肽抗体检测试剂盒 |
CN104198725B (zh) * | 2014-08-14 | 2016-04-06 | 上海睿康生物科技有限公司 | 抗环瓜氨酸肽抗体检测试剂盒 |
CN104764888A (zh) * | 2015-05-04 | 2015-07-08 | 潍坊市康华生物技术有限公司 | 一种抗环瓜氨酸肽抗体检测试剂盒 |
CN105548557B (zh) * | 2015-12-08 | 2018-05-08 | 苏州德沃生物技术有限公司 | 超敏乳胶增强免疫比浊检测试剂及其检测方法和应用 |
CN105548557A (zh) * | 2015-12-08 | 2016-05-04 | 苏州德沃生物技术有限公司 | 超敏乳胶增强免疫比浊检测试剂及其检测方法和应用 |
CN106153946A (zh) * | 2016-06-22 | 2016-11-23 | 浙江达美生物技术有限公司 | 一种抗环瓜氨酸肽的测定试剂及其制备方法 |
CN107390742A (zh) * | 2017-08-04 | 2017-11-24 | 天津理工大学 | 一种基于ladrc的全自动酶免分析仪孵育温控系统及工作方法 |
CN108456253A (zh) * | 2018-02-09 | 2018-08-28 | 中国科学院广州生物医药与健康研究院 | 一种重金属离子特异性二抗及其制备方法和应用 |
CN108456253B (zh) * | 2018-02-09 | 2021-06-08 | 中国科学院广州生物医药与健康研究院 | 一种重金属离子特异性二抗及其制备方法和应用 |
CN109100515A (zh) * | 2018-09-14 | 2018-12-28 | 苏州普瑞斯生物科技有限公司 | 一种测定抗环瓜氨酸肽抗体浓度的试剂盒及其制备方法 |
CN109724929A (zh) * | 2018-12-26 | 2019-05-07 | 镇江金太医学检验实验室有限公司 | 一种抗坏瓜氨酸肽抗体的检测方法 |
CN110824160A (zh) * | 2019-11-27 | 2020-02-21 | 迪亚莱博(张家港)生物科技有限公司 | 抗环瓜氨酸肽抗体检测试剂盒及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102507918B (zh) | 2014-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102507918B (zh) | 抗环瓜氨酸肽抗体测定试剂盒 | |
US11959912B2 (en) | Fluorescence immunochromatographic detection card and a preparation method therefor and use thereof | |
Mahler et al. | Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies | |
US8956823B2 (en) | Anti-antibody reagent | |
JP2019530875A5 (zh) | ||
JP2019535015A5 (zh) | ||
CN102901810B (zh) | 包被有前列腺特异性抗原抗体的胶乳颗粒的制备方法及psa胶乳增强免疫比浊法检测试剂盒 | |
CN101377492A (zh) | 胱抑素c测定试剂盒 | |
JP6749337B2 (ja) | 前立腺抗原標準およびその使用 | |
CN104215770A (zh) | 一种基于双粒子的视黄醇结合蛋白检测试剂盒 | |
WO2002039114A2 (en) | Improved assay and reagents or immunological determination of analyte concentration | |
CN108152512A (zh) | 肝素结合蛋白检测试剂盒及其制备方法 | |
AU2015241521B2 (en) | Immunoassay utilizing trapping conjugate | |
CN104849473A (zh) | 一种尿微量白蛋白检测试剂盒及其制备 | |
Wang et al. | Development of a novel chemiluminescence immunoassay for the detection of procalcitonin | |
CN102072960A (zh) | 一种样本中中性粒细胞明胶酶相关脂质运载蛋白的检测方法 | |
WO2011093459A1 (ja) | ヒトsCD14-STの分析方法 | |
EP0968422B1 (en) | Improving performance of binding assays by use of more than one label | |
CN112166323A (zh) | 自身抗体的直接免疫测定测量 | |
CN105334317A (zh) | 一种抗肝肾微粒体1抗体检测试剂盒及检测方法 | |
CN109142753A (zh) | 鳞状上皮细胞癌抗原化学发光免疫检测试剂盒及其制备方法 | |
Dai et al. | A paramagnetic microspheres based automation-friendly rapid chemiluminescent immunoassay method for sensitive detection of chicken interferon-γ | |
CN104142406A (zh) | 一种稳定的肌钙蛋白i检测试剂盒 | |
JP4556605B2 (ja) | 標的物質の測定方法および測定試薬 | |
CN105445474A (zh) | 一种抗SS-A(Ro60)抗体试剂盒及其检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: High tech Zone Tianchen road Chengdu City, Sichuan province 610000 No. 88 Applicant after: SICHUAN XINJIAN KANGCHENG BIOLOGICAL CO., LTD. Address before: 610000 Sichuan province Chengdu city Chengdu high tech Zone Tianchen Road No. 88 Applicant before: Sichuan Province Xincheng Biological Technology Co., Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: SICHUAN XINCHENG BIOTECHNOLOGY CO., LTD. TO: SICHUAN XINJIANKANGCHENG BIOLOG TECHNOLOGY CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Kit for determining anti-cyclic citrullinated peptide (Anti-CCP) antibody Effective date of registration: 20161214 Granted publication date: 20141029 Pledgee: Chengdu technology transfer (Group) Co., Ltd. Pledgor: SICHUAN XINJIAN KANGCHENG BIOLOGICAL CO., LTD. Registration number: 2016990001096 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20171222 Granted publication date: 20141029 Pledgee: Chengdu technology transfer (Group) Co., Ltd. Pledgor: SICHUAN XINJIAN KANGCHENG BIOLOGICAL CO., LTD. Registration number: 2016990001096 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |